Results 31 to 40 of about 5,917,592 (236)

Esophageal cyst producing CA19-9 and CA125 [PDF]

open access: yesInteractive CardioVascular and Thoracic Surgery, 2010
The patient was a 59-year-old woman in whom computed tomography revealed a posterior mediastinal cyst and ovarian cystoma at a medical check-up in March 2007. Blood tests showed high CA19-9 and CA125 levels. She underwent left adnexectomy for ovarian cystoma in July 2008 and histopathological examination led to a diagnosis of dermoid cyst.
Taichiro, Goto   +3 more
openaire   +2 more sources

Optimal value of CA19-9 determined by KRAS-mutated circulating tumor DNA contributes to the prediction of prognosis in pancreatic cancer patients

open access: yesScientific Reports, 2021
Despite the acceptance of carbohydrate antigen 19-9 (CA19-9) as a valuable predictor for the prognosis of pancreatic ductal adenocarcinoma (PDAC), its cutoff value remains controversial.
Fumiaki Watanabe   +12 more
doaj   +1 more source

Elevated Preoperative Serum CA19-9 Levels in Patients with Hepatocellular Carcinoma Is Associated with Poor Prognosis after Resection

open access: yesThe Scientific World Journal, 2013
Serum levels of the tumor marker CA19-9 have been reported to be elevated in patients with hepatocellular carcinoma (HCC), but its clinicopathologic significance is still unknown.
Yu-Ling Chen   +4 more
doaj   +1 more source

Preoperative CRP(−)/CEA(−)/CA19-9(−)/non-T4 in Stage III Colorectal Cancer Is Favorable Risk for Recurrence

open access: yesJournal of the Anus, Rectum and Colon, 2022
Objectives: We evaluated the prognostic impact of a novel C-reactive protein (CRP) cut-off value (0.6 mg/dl) and carcinoembryonic antigen (CEA)/carbohydrate antigen 19-9 (CA19-9) in stage II/III colorectal cancer.
Mitsunori Ushigome   +8 more
doaj   +1 more source

Raised CA19-9 in Autoimmune Pancreatitis [PDF]

open access: yesJournal of Digestive Endoscopy, 2020
AbstractAutoimmune pancreatitis (AIP) is a known autoimmune disorder of the pancreas, with a clinical presentation similar to that of carcinoma of the pancreas. CA19-9 levels can be the distinguishing feature between the two disorders. In rare instances, CA19-9 may be elevated in AIP.
Sridhar Sundaram, Deepak Kumar Gupta
openaire   +2 more sources

CA19-9 Level to Serum γ-Glutamyltransferase as a Potential Prognostic Biomarker in Patients with Pancreatic Head Carcinoma

open access: yes, 2021
Shao-Cheng Lyu,* Jing Wang,* Mengxiu Huang,* Han-Xuan Wang, Lin Zhou, Qiang He, Ren Lang Department of Hepatobiliary and Pancreaticosplenic Surgery, Beijing ChaoYang Hospital, Capital Medical University, Beijing, 100020, People’s Republic of China ...
Zhou L   +6 more
core  

Label-free multiplex immunoassay of AFP, CEA and CA19-9 by integrated microfluidic biosensor based on imaging ellipsometry

open access: yes, 2016
This study describes the development of alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA) and carbohydrate 19-9(CA19-9) multiplex immunoassay by integrated microfluidic device based on imaging ellipsometry (IMBIE). Different strategies for AFP, CEA
Zhang ST   +11 more
core   +1 more source

Cutoff value of carcinoembryonic antigen and carbohydrate antigen 19-9 elevation levels for monitoring recurrence in patients with resectable gastric adenocarcinoma

open access: yesThe International Journal of Biological Markers, 2009
Background The aim of this longitudinal study was to try and improve the specificity of carcinoembryonic antigen (CEA) and carbohydrate antigen (CA) 19-9 in monitoring tumor recurrence in patients with resectable gastric adenocarcinoma by setting ...
Miao-Zhen Qiu   +9 more
doaj   +1 more source

Upregulation of CA 19-9 in the Mouse Kidney Following Unilateral Ureteral Obstruction [PDF]

open access: yes, 2001
High serum levels of carbohydrate antigen19-9 (CA19-9) have been detected in patients with pancreatic cancer and described in several recent case reports of patients with hydronephrosis.
Aoki, Daiyu   +5 more
core  

CA19-9-low and Lewis(+) pancreatic cancer: A unique subtype.

open access: yes, 2017
339 Background: Pancreatic cancer is a lethal malignancy and patients often survive within one year. CA19-9 is the most important biomarker for pancreatic cancer and Lewis (-) individuals have no or scarce CA19-9 secretion. We have met several patients
Xian Jun Yu, Guopei Luo
core   +1 more source

Home - About - Disclaimer - Privacy